People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...
A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback